Limaprost is a prostaglandin E1 derivative and potent vasodilator used clinically to manage ischemic symptoms associated with thromboangiitis obliterans, as well as to improve gait ability and subjective… Read more











Limaprost is a prostaglandin E1 derivative and potent vasodilator used clinically to manage ischemic symptoms associated with thromboangiitis obliterans, as well as to improve gait ability and subjective symptoms in patients with acquired lumbar spinal canal stenosis. This category features a comprehensive range of Limaprost reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for critical analytical testing, impurity profiling, and method validation to ensure consistent drug product quality. By incorporating stable isotope-labelled standards, such as deuterium-labelled variants, researchers can improve the accuracy of mass spectrometry-based quantification. These diverse reference materials support stringent regulatory compliance and quality control processes throughout the drug development lifecycle, ensuring that researchers and quality assurance teams have the necessary analytical tools to support the rigorous evaluation of this active pharmaceutical ingredient.